October 04, 2018
Rose
It's not clear who funds the new group or who is running its day-to-day operations. But the Alliance to Protect Medical Innovation does have a target for its finger-pointing: insurers and pharmacy benefits managers. Meanwhile, drug pricing advocates are criticizing President Donald Trump's new trade deal.
from Kaiser Health News https://ift.tt/2xXWMFa
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment